|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Operating activities: | |||||
| Net income | |||||
| Adjustments to reconcile net income to net cash provided by operating activities: | |||||
| Depreciation, depletion and accretion of asset retirement obligation | |||||
| Impairment loss | |||||
| Amortization of intangible assets | |||||
| Net loss (gain) on disposal of assets | |||||
| Accounts Receivable, Credit Loss Expense (Reversal) | |||||
| Amortization of deferred financing cost | |||||
| Accretion of debt discount | |||||
| Loss on extinguishment of debt | |||||
| Deferred income taxes | |||||
| Stock-based compensation, net | |||||
| Employee stock purchase plan compensation | |||||
| Changes in assets and liabilities: | |||||
| Accounts receivable | |||||
| Unbilled receivables | |||||
| Inventory | |||||
| Prepaid expenses and other assets | |||||
| Deferred revenue | |||||
| Settlement of asset retirement obligation | |||||
| Accounts payable | |||||
| Accrued expenses and other liabilities | |||||
| Net cash provided by operating activities | |||||
| Investing activities: | |||||
| Acquisition, net of cash acquired | |||||
| Purchases of property, plant and equipment | |||||
| Proceeds from disposal of assets | |||||
| Net cash used in investing activities | |||||
| Financing activities: | |||||
| Dividend payments to stockholders | |||||
| Proceeds from the issuance of notes payable | |||||
| Repayments of notes payable | |||||
| Proceeds from revolving credit facility | |||||
| Repayment of revolving credit facility | |||||
| Payment of contingent consideration | |||||
| Payments under finance leases | |||||
| Payment of deferred financing and debt issuance costs | |||||
| Payment for debt extinguishment costs | |||||
| Employee stock purchase plan issuance | |||||
| Royalty stock issuance | |||||
| Repurchase of treasury stock from Repurchase Program | |||||
| Net cash used in financing activities | |||||
| Net increase (decrease) in cash and cash equivalents | |||||
| Cash and cash equivalents at beginning of year | |||||
| Cash and cash equivalents at end of year | |||||
| Payments For Repurchase Of Common Stock, From Repurchase Program | |||||
Loading...